Article detail · 2023 · article
Phenotypic and functional characterization of subpopulation of Imatinib resistant chronic myeloid leukemia cell line
Journal
Adv Med Sci.
The ISSN points to another catalog journal; the name is from the YÖKSİS record.
ISSN1896-1126
YÖKSİS
OpenAlex
Year2023
Citations5OpenAlex
Citations4Semantic Scholar
Percentile%74.2
FWCI0.91.00 = world average
Scopus (SJR)Q2
WoS (JCR)Q3
Data source split
- YÖKSİSYÖKSİS article record
- YÖKSİS venueAdv Med Sci.
- Catalog match (ISSN)Advances in Medical Sciences
- OpenAlexOpenAlex enrichment (abstract, citations, topics)
- Semantic Scholarcitation count (not merged with OpenAlex)
Abstract
Abstract not compiled yet; it will appear after the DergiPark / OpenAlex queue runs.
Topics
Citations
OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.
5citationsOpenAlex · cited_by_count (cache / database)
11 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).
- 2024 Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemiaCitations 14 · OpenAlex
- 2024 Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemiaCitations 14 · OpenAlex
- 2024 Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemiaCitations 14 · OpenAlex
- 2024 Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemiaCitations 14 · OpenAlex
- 2024 Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemiaCitations 14 · OpenAlex
- 2025 Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia CellsCitations 0 · OpenAlex
- 2025 Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia CellsCitations 0 · OpenAlex
- 2025 Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia CellsCitations 0 · OpenAlex
- 2025 Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia CellsCitations 0 · OpenAlex
- 2024 P01-50 Mitochondria-specific targeting to overcome imatinib resistance in chronic myeloid leukemia cellsCitations 0 · OpenAlex